Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | UNK | — | OT |
patient needed to be revaccinated for YF VAX when it was injected intramuscular instead of subcutaneous with no adverse event; Initial information received on 23-Jun-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who received Yellow fever vaccine - [YF-VAX] intramuscular instead of subcutaneous with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of 0.5ml of suspect Yellow fever vaccine - Solution for injection standard strength, frequency-once (lot number and expiry date-unknown) via intramuscular route in unknown administration site for Immunization instead of subcutaneous with no adverse event (incorrect route of product administration) (latency-same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.